You Q - Search Results

1

Strategies for Targeting Serine/Threonine Protein Phosphatases with Small Molecules in Cancer.

Zhang Q, Fan Z, Zhang L, You Q, Wang L. Zhang Q, et al. Among authors: you q. J Med Chem. 2021 Jul 8;64(13):8916-8938. doi: 10.1021/acs.jmedchem.1c00631. Epub 2021 Jun 22. J Med Chem. 2021. PMID: 34156850 Review.

2

Design, synthesis and biological evaluation of novel compounds with conjugated structure as anti-tumor agents.

Su H, Nebbioso A, Carafa V, Chen Y, Yang B, Altucci L, You Q. Su H, et al. Among authors: you q. Bioorg Med Chem. 2008 Sep 1;16(17):7992-8002. doi: 10.1016/j.bmc.2008.07.066. Epub 2008 Jul 29. Bioorg Med Chem. 2008. PMID: 18701301

3

Recent progress of SRC family kinase inhibitors as anticancer agents.

Cao X, You QD, Li ZY, Wang XJ, Lu XY, Liu XR, Xu D, Liu B. Cao X, et al. Mini Rev Med Chem. 2008 Sep;8(10):1053-63. doi: 10.2174/138955708785740634. Mini Rev Med Chem. 2008. PMID: 18782057 Review.

4

The design, synthesis and biological evaluation of 7-alkoxy-4-heteroarylamino-3-cyanoquinolines as dual inhibitors of c-Src and iNOS.

Cao X, You QD, Li ZY, Liu XR, Xu D, Guo QL, Shang J, Chern JW, Chen ML. Cao X, et al. Bioorg Med Chem Lett. 2008 Dec 1;18(23):6206-9. doi: 10.1016/j.bmcl.2008.10.006. Epub 2008 Oct 5. Bioorg Med Chem Lett. 2008. PMID: 18930653

5

Studies on chemical structure modification and biology of a natural product, gambogic acid (I): Synthesis and biological evaluation of oxidized analogues of gambogic acid.

Wang J, Zhao L, Hu Y, Guo Q, Zhang L, Wang X, Li N, You Q. Wang J, et al. Among authors: you q. Eur J Med Chem. 2009 Jun;44(6):2611-20. doi: 10.1016/j.ejmech.2008.09.034. Epub 2008 Oct 7. Eur J Med Chem. 2009. PMID: 18996626

6

3D-QSAR studies of HDACs inhibitors using pharmacophore-based alignment.

Chen Y, Li H, Tang W, Zhu C, Jiang Y, Zou J, Yu Q, You Q. Chen Y, et al. Among authors: you q. Eur J Med Chem. 2009 Jul;44(7):2868-76. doi: 10.1016/j.ejmech.2008.12.008. Epub 2008 Dec 16. Eur J Med Chem. 2009. PMID: 19136179

7

Discovery of potential new InhA direct inhibitors based on pharmacophore and 3D-QSAR analysis followed by in silico screening.

Lu XY, Chen YD, Jiang YJ, You QD. Lu XY, et al. Eur J Med Chem. 2009 Sep;44(9):3718-30. doi: 10.1016/j.ejmech.2009.03.043. Epub 2009 Apr 8. Eur J Med Chem. 2009. PMID: 19428156

8

Researches toward potassium channels on tumor progressions.

Shen Z, Yang Q, You Q. Shen Z, et al. Among authors: you q. Curr Top Med Chem. 2009;9(4):322-9. doi: 10.2174/156802609788317874. Curr Top Med Chem. 2009. PMID: 19442203 Review.

9

Drug discoveries towards Kv1.5 potassium channel.

Yang Q, Wang X, Du L, Li M, You Q. Yang Q, et al. Among authors: you q. Curr Top Med Chem. 2009;9(4):339-47. doi: 10.2174/156802609788317810. Curr Top Med Chem. 2009. PMID: 19442205

10

Synthesis and bioactivity of substituted indan-1-ylideneaminoguanidine derivatives.

Zhang R, Dong J, Xu YG, Hua WY, Wen N, You QD. Zhang R, et al. Eur J Med Chem. 2009 Sep;44(9):3771-6. doi: 10.1016/j.ejmech.2009.04.036. Epub 2009 May 5. Eur J Med Chem. 2009. PMID: 19482383

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,624 results

Search Page

Filters